Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year by Cuschieri, Sarah et al.
RESEARCH Open Access
Estimating the direct Covid-19 disability-
adjusted life years impact on the Malta
population for the first full year
Sarah Cuschieri1*, Neville Calleja2,3, Brecht Devleesschauwer4,5 and Grant M. A. Wyper6
Abstract
Background: Disability-adjusted life years (DALYs) combine the impact of morbidity and mortality, allowing for
comprehensive comparisons of the population. The aim was to estimate the DALYs due to Covid-19 in Malta
(March 2020–21) and investigate its impact in relation to other causes of disease at a population level.
Methods: Mortality and weekly hospital admission data were used to calculate DALYs, based on the European
Burden of Disease Network consensus Covid-19 model. Covid-19 infection duration of 14 days was considered.
Sensitivity analyses for different morbidity scenarios, including post-acute consequences were presented.
Results: An estimated 70,421 people were infected (with and without symptoms) by Covid-19 in Malta (March
2020–1), out of which 1636 required hospitalisation and 331 deaths, contributing to 5478 DALYs. These DALYs
positioned Covid-19 as the fourth leading cause of disease in Malta. Mortality contributed to 95% of DALYs, while
post-acute consequences contributed to 60% of morbidity.
Conclusions: Covid-19 over 1 year has impacted substantially the population health in Malta. Post-acute
consequences are the leading morbidity factors that require urgent targeted action to ensure timely
multidisciplinary care. It is recommended that DALY estimations in 2021 and beyond are calculated to assess the
impact of vaccine roll-out and emergence of new variants.
Keywords: Burden of disease, Disability-adjusted life years, DALY, YLD, YLL, Population health, Malta, European
burden of disease network, Coronavirus, Covid-19
Background
The outbreak of novel coronavirus SARS-CoV-2 has been
a global pandemic since early 2020 [1]. The small Euro-
pean state of Malta reported its first Covid-19 case on the
7th of March 2020 [2]. The first Covid-19 wave was well
controlled in Malta, with a relatively low mortality rate
and a total cumulative positive cases of 108 per 100,000
[3]. The second Covid-19 wave initiated in mid-Summer
and this saw a high mortality and admission rates to
hospital [4, 5]. The positivity and mortality rates were con-
stantly high until mid-March 2021, where another insti-
tuted lockdown curbed the community spread [6]. Up till
the end of March 2021, 6562 positive cases per 100,000
population have been reported with 88 deaths per 100,000
population [2].
Burden of disease assessments allow the estimation of
a disease impact on a population by measuring the mor-
bidity and mortality attribution and presenting it
through a single metric called disability-adjusted life
years (DALYs) [7]. Morbidity occurrence is translated
through the estimation of years lived with disability
(YLD) following the adjustment for the severity and the
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disability suffered due to a disease or injury. The mortal-
ity counts due to the disease or injury, are translated
into estimates of years of life lost to premature mortality
(YLL), using age-conditional life tables. DALYs are esti-
mated by the combination of YLD and YLL [7]. This
metric is a popular way used to assess the health impact
at a population level and then translated as evidence to
influence national policy makers.
The aim of this study was to estimate, for the first
time, the direct impact of Covid-19 on the population of
Malta for the first year (March 2020–2021). We also set
to investigate the likely Covid-19 impact in relation to
other causes of disease and injury, at a population level.
Methods
Data
Covid-19 mortality data between March 2020 and
March 2021 were recorded from the daily Covid-19 bul-
letins issued by the Malta Ministry of Health [2]. How-
ever, mortality data did not differentiate from those
dying with Covid-19 from those dying due to Covid-19,
in line with WHO recommendations on assigning
underlying cause of death [8]. Also, this group-level
COVID-19 data did not provide details on the presence
of any other underlying comorbidities among the in-
fected individuals.
The Covid-19 positive cases were sub-divided ac-
cording to the different health states, as shown in
Table 1, based on the European Burden of Disease
Network and the European Centre of Disease Preven-
tion and Control (ECDC) Covid-19 consensus disease
model [9]. Daily positive case numbers have been re-
ported by the Malta Ministry of Health from the on-
set of the pandemic in Malta [2]. However, data on
the different health states of the Covid-19 positive
cases were provided on a weekly basis, every Friday,
from the 7th of August 2020, following the initiation
of the second wave in Malta [5]. Prior to this period,
the Covid-19 situation was well controlled [3, 10].
Hence, weekly Covid-19 health states were not
publicly provided except for the monthly intensive
care unit (ICU – critical cases) admissions due to
Covid-19 [11]. Therefore, estimations for the hospital-
ized Covid-19 cases (non-ICU, i.e., severe cases) from
March to July 2020 were performed. An assumption
was made that the proportion of Covid-19 admissions
to hospital in August in relation to the total positive
cases (not requiring ICU) was the same as that
throughout March to July 2020. It was hence assumed
that 1.3% of the Covid-19 cases not admitted to the
ICU, required admission to a hospital ward i.e. were
‘severe’ cases.
Considering that in Malta a high swabbing rate and effi-
cient contact tracing, up to secondary contact, has been in ef-
fect from the onset of the pandemic, it was noted that 20%
of the reported positive cases (not requiring hospitalisation,
i.e., moderate cases) were actually asymptomatic [3, 5, 12].
Hence, for this study’s analyses, a reduction of 20% from the
moderate cases was performed. However, the literature indi-
cates that a proportion of Covid-19 will not be picked up
through polymerase chain reaction (PCR) testing [13]. In-
deed, the PCR sensitivity has been reported to be 97.2% [14].
Based on this, we have estimated that cases represent 80% of
all infections, so have upscaled our estimates to reflect this to
estimate the total number of asymptomatic and symptomatic
infections. Additionally, it has been noted that approximately
20% of reported cases were actually asymptomatic [3, 5, 12].
To reflect this, we have also reduced the number of moder-
ate cases by 20%, since by virtue of requiring healthcare as-
sistance, any severe or critical cases would be symptomatic.
Therefore, we estimated that asymptomatic cases repre-
sented a total of 36% of all cases as follows: (i) 20% of all
cases are asymptomatic and not reported (ii) 20% of the re-
ported cases (80%) are asymptomatic i.e. 16% of all cases.
Analyses
The modelling approach applied by this study to calcu-
late the Covid-19 DALYs was based on the European
Burden of Disease Network and the ECDC consensus
disease model [9].
Table 1 Covid-19 health states, descriptions and disability weights [9]
Health state Description Disability weight (95%
uncertainty interval)









Has symptoms and causing great difficulty with daily activities. 0.133 (0.088–0.190)
Critical (Hospitalised; intensive
care)
Intensive care admission with or without respiratory support 0.655 (0.579–0.727)
Post-acute consequences Person still feels symptoms such as tired, fatigue, pain all over body, persisting
after the acute infection
0.219 (0.148–0.308)
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YLL was estimated by combining the death counts by
five-year age-groups and sex. The estimates were calcu-
lated by multiplying the number of deaths in each age-
group by the age-conditional remaining life expectancy
from the Global Burden of Disease (GBD) Study 2019
reference life table, where the same values are assigned
to both males and females [15].
The symptomatic duration of 14 days was considered
for each health state (critical, severe, moderate), following
local and international reported durations of Covid-19 in-
fection respectively [16, 17]. Person-years were calculated
as the sum of cases for each symptomatic health states
(critical, severe, moderate), multiplied by 14, divided by
365.25, reflecting the contribution of individual days to a
complete year. This was carried out since DALYs use a
year as the unit of time. An estimate of the post-acute
consequence (long-Covid) YLD was calculated, where it
was assumed that 13.3% (one in seven) of the total Covid-
19 patients (symptomatic and asymptomatic) would suffer
from long-Covid for a duration of 28 days [18]. The dis-
ability weights used for each health status was derived
from the European Disability Weight Study (EDWS) and
GBD 2019, as shown in Table 1 [19, 20].
YLD was estimated by multiplying person-years of in-
fection with the disability weight for each health status
(as per Table 1). The disability weight’s uncertainty
levels (UI) were also considered to measure the upper
and lower limits of the YLD. DALYs were then calcu-
lated through the summation of YLL and YLD. The
upper and lower limits of the DALYs were also calcu-
lated based on the UIs of the YLD.
Our estimate of Covid-19 DALYs was compared to
the 2019 leading ranked causes of disease and injury for
Malta, using estimates from GBD 2019 [21].
Scenario analyses
A number of uncertainties were present in our analyses
especially when estimating YLD. The health state case
numbers were not available prior to August 2020 (except
for ICU on a monthly basis). When health state data was
available, the cases were a snapshot of one particular day
(Friday). Another uncertainty was the proportion of
cases that suffered from post-acute Covid-19 conse-
quences. Thus, in order to quantify the impact of these
uncertainties, sensitivity analyses were performed. Sensi-
tivity analyses were performed on the moderate cases
and the post-acute consequences, since these were likely
the most uncertain estimates. The sensitivity analyses
assessed for the effect of an increase in moderate cases
by 10, 25 and 50% on the DALYs. We also assessed the
effect of different transition probabilities from an acute
to post-acute consequence have on the DALYs, when
considering all Covid-19 cases and then symptomatic
cases only. Finally, different scenarios were assumed with
half or double the duration of post-acute consequences
and different proportions of moderate cases, in order to
minimise and maximise the YLD.
Results
Over the course of a year (March 2020 – March 2021),
an estimated 70,421 people were infected by Covid-19 in
Malta, both with and without symptoms. When consid-
ering the symptomatic cohort and taking into the ac-
count the duration of the Covid-19 infection; for an
infection duration of 14 days, this reflected 1570 person-
years. These generated a YLD of 93, as shown in Table 2.
Out of the three health states, the moderate symptom-
atic cohort translated the most to the symptomatic YLD.
Post-acute consequences were estimated to have affected
9366 patients with a contributing YLD of 157, if symp-
toms persisted for 28 days. Out of the different health
states, post-acute consequences had the highest impact
on YLD while the severe cases had the lowest impact on
YLD. The mortality for this time period was of 331
deaths, contributing to 5229 YLLs.
It was estimated that the DALYs due to Covid-19 were
5478. The highest contributor factor to the DALYs was
mortality, with YLL representing 95% of the DALYs with
16 YLL per Covid-19 death.
On comparing the DALYs for the top-ranking diseases
and injuries as reported by GBD 2019 for Malta to this
study’s estimated Covid-19 DALYs, it was noted that the
Covid-19 DALY ranked fourth, after ischemic heart dis-
ease (13,594 DALYs), low back pain (7106 DALYs) and
diabetes (5796 DALYs), but before stroke (5096 DALYs).
Scenario analyses
A number of different sensitivity analyses, which varied
assumptions on moderate cases (symptomatic commu-
nity) and post-acute consequences health statuses were
performed to evaluate their impact on DALYs, as shown
in Table 3. Additionally, a combination of assumptions
was performed to minimise and maximise the impact of
YLD, with a range of 115 to 3606 (Table 3). The differ-
ent defining scenarios involving the post-acute conse-
quences and the combination assumption maximising
the YLD, led to a higher estimated DALY than that esti-
mated for Malta 2020. However, only when maximising
the YLD, did the DALY represent a higher-ranking pos-
ition for the cause of disease and disability for Malta,




DALYs due to Covid-19 in Malta were likely to have had
the fourth largest population health impact relative to
other diseases and injuries for 2020. The majority of the
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population health loss was due to mortality as it repre-
sented 95% of DALYs with 16 YLL per Covid-19 death.
On comparing to the Scottish Covid-19 BoD study, our
study’s mortality contributed to a lesser percentage to
the DALYs than Scotland, where the latter reported
mortality to contribute to 98% of DALYs [22].
In our study, morbidity was driven mostly by post-
acute consequences, followed by symptomatic commu-
nity cases (moderate). Indeed, when maximizing both
post-acute consequences and moderate cases, the esti-
mated DALY exceeded the impact of Covid-19 from
fourth to the second leading cause of disability in Malta.
Therefore, although Covid-19 individuals that require
hospitalisation, with or without intensive care support,
have a considerable ill-health impact, the post-acute
consequences, also called “long-haulers” might pose the
largest cumulative impact on the population health, al-
though this follows a degree of uncertainty. This finding
corresponds with the Scottish Covid-19 DALYs estimate
although different time periods were considered in this
study [23]. Nevertheless, it needs to be noted that fol-
lowing a comparison analyses between a Malta national
burden of disease study for low back pain (LBP) to the
GBD LBP estimates for Malta, it was concluded that the
GBD overestimated the LPB burden [24]. Hence, it is
likely that the Covid-19 DALYs estimated in this study
may place at a higher-ranking position than fourth lead-
ing cause of disability in Malta.
Table 2 Measure of the population health impact of Covid-19
Health State Morbidity Mortality DALYs (UI 95%)
Persons Person - years YLD (UI 95%) Deaths YLL
Covid-19 infection 70,421 250 (166–352) 331 5229 5478 (5395 - 5581)
Symptomatic Covid-19 1570 93 (60–131)
Moderate 1507 77 (48–112)
Severe 49 7 (4–9)
Critical 14 9 (8–10)
Post-acute consequencesa 9366 718 157 (106–221)
aduration of 28 days
Table 3 Covid-19 Morbidity sensitivity analyses with corresponding impact on YLD and DALYs, Malta, 2020
Impacted health status Sensitivity YLD (UI 95%) DALYs (UI)
Moderate - Community cases Increase by 10% 256 (170–361) 5484 (5399 - 5589)
Increase by 25% 267 (178–377) 5495 (5406 - 5606)
Increase by 50% 286 (190–405) 5514 (5418 - 5633)
Post-acute consequences for all cases Transition probability of 26.6% 406 (272–571) 5634 (5501 - 5800)
Transition probability of 6.65% 171 (113–241) 5399 (5342 - 5470)
Duration of 56 days 406 (272–571) 5634 (5501 - 5800)
Duration of 14 days 171 (114–241) 5399 (5342 - 5470)
Post-acute consequences for symptomatic cases
only
Transition probability of 26.6% 275 (184–388) 5504 (5413 - 5617)
Transition probability of 6.65% 138 (92–195) 5367 (5320 - 5424)
Duration of 56 days 275 (184–388) 5504 (5413 - 5617)
Duration of 14 days 138 (92–195) 5367 (5320 - 5424)
Combination to minimize the impact of YLD No increse in Moderate case 115 (76–163) 5344 (5305 - 5392)
Transition to post-acute consequences for symptomatic
only
Half the transition of acute to post consequences (6.65%)
Half the duration for post-acute consequences (14 days)




Transition to post-acute for All cases
Double transition of acute to post consequences (26.6%)
Double duration for post-acute consequences (56 days)
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Strengths and weaknesses
The YLL calculation was based on the national reported
cases (hospital, nursing homes and private residence
deaths) that died while with Covid-19. Distinction was
not made between those that died with Covid-19 or due
to Covid-19. Since the onset of the pandemic, all deaths
at hospital (even if initially negative for Covid-19), were
tested for Covid-19 post-mortem however, deaths in pri-
vate residents were not unless suspected by relatives that
the deceased might have had Covid-19. This is more
likely to have overestimated DALYs due to Covid-19,
however this is counter-acted by the fact that deaths
from early in the pandemic would have been less likely
to have been identified as dying with Covid-19. The val-
idity of the mortality estimate is furthermore supported
by recent information on excess mortality. Compared to
2019, there have been 317 more deaths in 2020, which is
in line with the number of reported Covid-19 deaths.
Furthermore, caution needs to be put forward when
comparing our study results to other Covid-19 burden
of disease studies according to the mortality definition
considered for the DALYs estimation.
The aspirational life table was used to calculate the
YLL in order to facilitate comparative research consider-
ing that Covid-19 is a global issue, although acknow-
ledge that this choice is an area of intense debate [25].
All admissions to hospital were tested for Covid-19,
with PCR testing repeated if any symptoms develop dur-
ing the patient’s stay or the patient needed to undergo
an invasive procedure. Hence, the Covid-19 pick up rate
for in-patient cases was efficient. However, hospital data
was only freely available on a weekly basis from August.
Although assumptions had to be made for this time
period, acute YLD is very small in relation to the YLL
and so the impact of these assumptions will be minimal.
However, one cannot dismiss the possibility that the as-
sumptions might have led to overestimations or under-
estimations for some cases.
At a community level, a high swabbing rate has been
implemented from the very start of the pandemic in
Malta with contact tracing up to the second contact of
an infected person [3]. Therefore, Covid-19 positive
cases, whether symptomatic or asymptomatic, were
picked up at an early stage of the disease. Based on the
literature it was assumed that the total Covid-19 popula-
tion consisted of an additional 20% Covid-19 asymptom-
atic individuals that were never picked up [13].
However, this was an estimated proportion originating
from the literature and does not necessarily reflect the
local undetected Malta cases, hence we cannot exclude
the possibility of overestimations or underestimations of
this asymptomatic cohort.
The disease model to calculate the health loss due to
Covid-19 morbidity was based on the European Burden
of Disease Network and ECDC consensus method,
which was adopted for both prevalence- or pathogen-
based YLD calculations [9]. Meaning that any future pre-
senting long-Covid conditions such as respiratory condi-
tions, will be attributed to their relevant non-
communicable diseases through prevalence data.
It needs to be noted that comorbidity data for the
Covid-19 positive cases was not available. Common co-
morbidities such as diabetes and cardiovascular disease
have been reported to increase the risk of acquiring
Covid-19 infection (morbidity) as well as have a higher
chance of mortality due to Covid-19 [26, 27]. However,
burden of disease studies, including the Global Burden
of Disease (GBD) Study, perform adjustments to down-
scale YLD to correct for multimorbidity. Indeed, it is un-
common for the YLL to be adjusted in such cases [28].
In terms of our study, since the major contribution to
the DALYs was from the YLL rather than YLD, any ad-
justments to reduce the YLD would not have influenced
our findings.
In our calculations, the post-acute consequences were
based on assumptions since long Covid-19 remains
largely uncertain and different entities provide different
definitions and durations [29, 30]. Indeed, the scenario
analyses were performed to try out a number of different
assumptions and scenarios, while evaluating the corre-
sponding DALYs. However, since the YLD contributed
to only 5% of the DALYs, fluctuations in post-acute con-
sequences had a greater impact on DALYs only when
maximizing the YLD health status outcome. It is recom-
mended that further research is performed on post-
acute consequences to have a better understanding on
the progress of this condition.
Conclusions
Covid-19 has bestowed a substantial burden upon Mal-
ta’s population health. This study estimates the direct
impact of Covid-19 in Malta and not the impact of lock-
downs or implemented mitigation measures instituted
throughout the duration of this pandemic. From our
analyses it could be observed that Covid-19 presented as
a novel disease in March 2020, however over 1 year it
became the fourth leading cause of disability among the
population. The burden of disease methodology used
assessed for both the direct and indirect impacts of
Covid-19. Indeed, it was clear that the largest morbidity
impact of Covid-19 was arising from post-acute conse-
quences. Although this is still an unknown territory,
where even the definition is still debatable [29], it is clear
that those that become ‘long haulers’ are attributing to
higher DALY and inevitably will have a higher burden
on the healthcare system. Indeed, more than 50 different
symptoms have been reported to be experienced by
these ‘long haulers’ with the commonest symptom being
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fatigue followed by headaches [31]. Therefore, it is rec-
ommended that further research on long Covid-19 is
conducted at a national level. Additionally, long Covid-
19 should be considered as an urgent public health mat-
ter with engagement of a multi-disciplinary service to
provide targeted healthcare service to this sub-
population.
Since the end of December 2020, Malta, has been ad-
ministering Covid-19 vaccination to the population
through a priority system [32]. Indeed, up to the time of
writing (3rd May 2021), Malta has the fastest vaccination
roll-out within the European Union (EU), with 25% of
the total eligible population fully vaccinated and 54%
having had the first dose [2]. Covid-19 vaccination is
considered as the tool to tackle Covid-19 infection.
Hence it is recommended that DALYs estimations are
measured periodically during 2021 and beyond to deter-
mine the vaccines’ impact on the population, as well as
determine the effect of emerging variants.
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